<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Preoperative <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> therapy (CRT) significantly decreases local recurrence in locally advanced <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Various biomarkers in biopsy specimens obtained before CRT have been proposed as predictors of response </plain></SENT>
<SENT sid="2" pm="."><plain>However, reliable biomarkers remain to be established </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND MATERIALS: The study group comprised 101 consecutive patients with locally advanced <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> who received preoperative CRT with oral <z:chebi fb="0" ids="17568">uracil</z:chebi>/tegafur (UFT) or S-1 </plain></SENT>
<SENT sid="4" pm="."><plain>We evaluated histologic findings on <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin (H&amp;E) staining and immunohistochemical expressions of Ki67, p53, p21, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in biopsy specimens obtained before CRT and 7 days after starting CRT </plain></SENT>
<SENT sid="5" pm="."><plain>These findings were contrasted with the histologic response and the degree of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In biopsy specimens obtained before CRT, histologic marked regression according to the Japanese Classification of Colorectal <z:mp ids='MP_0002038'>Carcinoma</z:mp> (JCCC) criteria and the degree of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage on <z:chebi fb="8" ids="32594,32595">barium</z:chebi> enema examination (BE) were significantly greater in patients with p21-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than in those with p21-negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P=.04 and P&lt;.01, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>In biopsy specimens obtained 7 days after starting CRT, pathologic complete response, histologic marked regression according to both the <z:mp ids='MP_0010537'>tumor regression</z:mp> criteria and JCCC criteria, and T downstaging were significantly greater in patients with <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-positive and p21-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than in those with <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-negative (P&lt;.01, P=.02, P=.01, and P&lt;.01, respectively) or p21-negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P=.03, P&lt;.01, P&lt;.01, and P=.02, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>The degree of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage on both BE as well as MRI was significantly greater in patients with <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-positive and with p21-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than in those with <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-negative or p21-negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Histologic changes in H&amp;E-stained biopsy specimens 7 days after starting CRT significantly correlated with pathologic complete response and marked regression on both JCCC and <z:mp ids='MP_0010537'>tumor regression</z:mp> criteria, as well as with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage on BE and MRI (P&lt;.01, P&lt;.01, P&lt;.01, P&lt;.01, and P=.03, respectively) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Immunohistochemical expressions of p21 and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> together with histologic changes on H&amp;E-stained biopsy specimens obtained 7 days after starting CRT are strong predictors of the response to CRT </plain></SENT>
</text></document>